• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    12/18/23 1:05:04 PM ET
    $ADD
    $AHG
    $AIMD
    $ARQT
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Real Estate
    Get the next $ADD alert in real time by email

    Shares of Lantheus Holdings, Inc. (NASDAQ:LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.

    Lantheus Holdings shares dipped 22.5% to $58.93 on Monday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Invivyd, Inc. (NASDAQ:IVVD) shares surged 170% to $4.40 after the company reported positive initial results from ongoing CANOPY Phase 3 pivotal clinical trial investigating VYD222 for the Prevention of COVID-19.
    • Cuentas Inc. (NASDAQ:CUEN) shares climbed 71.6% to $2.37.
    • iCoreConnect Inc. (NASDAQ:ICCT) shares jumped 49.4% to $2.54 after surging over 73% on Friday.
    • ZimVie Inc. (NASDAQ:ZIMV) gained 42.8% to $16.03 after the company disclosed an agreement to sell its spine business to H.I.G. Capital for $375 million.
    • Biomerica, Inc. (NASDAQ:BMRA) climbed 42.4% to $1.41. Biomerica received FDA 510(k) clearance for its Hp Detect Stool Antigen ELISA test, designed to detect the presence of the H. pylori bacteria.
    • Akso Health Group (NASDAQ:AHG) gained 41.6% to $0.8499.
    • Energy Services of America Corporation (NASDAQ:ESOA) surged 35.4% to $4.7399 following FY23 earnings results.
    • LQR House Inc. (NASDAQ:LQR) gained 30.9% to $3.3649.
    • United States Steel Corporation (NYSE:X) rose 26.5% to $49.77 after Nippon Steel announced it will acquire the company for $55 per share in an all-cash transaction.
    • Color Star Technology Co., Ltd. (NASDAQ:ADD) climbed 26.5% to $0.50.
    • ZK International Group Co., Ltd. (NASDAQ:ZKIN) rose 22.3% to $1.26.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares gained 22.2% to $0.2750 after dipping around 24% on Friday.
    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) gained 21.3% to $2.96 after the FDA approved the company's Zoryve topical foam, 0.3% for seborrheic dermatitis in individuals nine years and older.
    • Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) climbed 20.5% to $0.6143. Noble Capital Markets initiated coverage on Cadrenal Therapeutics with an Outperform rating and announced a price target of $4.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) shares rose 18% to $0.0537 after declining 11% on Friday.
    • Ideal Power Inc. (NASDAQ:IPWR) gained 16.7% to $9.06.
    • NightHawk Biosciences, Inc. (NASDAQ:NHWK) gained 14% to $0.43 as the company announced major milestone with completion of manufacturing run for a premier U.S.-based biopharmaceutical company.
    • James River Group Holdings, Ltd. (NASDAQ:JRVR) gained 12.8% to $9.58.
    • B. Riley Financial, Inc. (NASDAQ:RILY) rose 10.8% to $22.66.
    • Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) shares surged 10.4% to $0.16 after falling over 6% on Friday.
    • Ontrak, Inc. (NASDAQ:OTRK) rose 9.6% to $0.45 after falling over 8% on Friday.
    • Cleveland-Cliffs Inc. (NYSE:CLF) gained 8.7% to $20.33 after the company issued a statement regarding the proposed acquisition of U.S. Steel by Nippon Steel.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) rose 7.3% to $321.98.

    Losers

    • Ebix, Inc. (NASDAQ:EBIX) shares fell 70.6% to $1.45  after the company and certain US affiliates filed for protection under Chapter 11 and reached a stalking horse agreement to sell its North American Life and Annuity assets to Zinnia.
    • Jin Medical International Ltd. (NASDAQ:ZJYL) dipped 52.1% to $13.43.
    • Cara Therapeutics, Inc. (NASDAQ:CARA) declined 51.1% to $0.6010 as the company announced outcome from dose-finding Part A of KIND 1 study evaluating oral difelikefalin for moderate-to-severe pruritus in patients with atopic dermatitis.
    • Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) shares fell 48.5% to $1.7090. The FDA has issued a Complete Response letter to Checkpoint Therapeutics' Cosibelimab Biologic License Application for metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.
    • Structure Therapeutics Inc. (NASDAQ:GPCR) fell 47.1% to $31.27 after the company announced a comprehensive development program update for GSBR-1290.
    • Near Intelligence, Inc. (NASDAQ:NIR) shares fell 43.9% to $0.0331 after dipping 20% on Friday.
    • Minerva Surgical, Inc. (NASDAQ:UTRS) shares fell 38.3% to $1.7375. On Dec. 15, 2023, Minerva Surgical notified the Nasdaq of its intent to file a Form 25 with the SEC on or about Dec. 26, 2023 to effect the voluntary delisting of the company's common stock from Nasdaq.
    • Maison Solutions Inc. (NASDAQ:MSS) shares fell 38% to $1.55 after dipping 83% on Friday.
    • SunPower Corporation (NASDAQ:SPWR) fell 35% to $3.9899 after the company said substantial doubt exists about its ability to continue as a going concern.
    • PureCycle Technologies, Inc. (NASDAQ:PCT) declined 34.3% to $3.2563 after the company issued Ironton
    • operations update.
    • Fortress Biotech, Inc. (NASDAQ:FBIO) fell 22.8% to $2.37.
    • Shengfeng Development Limited (NASDAQ:SFWL) dipped 22.2% to $7.72.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) fell 22.2% to $0.7938.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) declined 21.5% to $5.54.
    • Gaotu Techedu Inc (NYSE:GOTU) fell 19.6% to $3.7250.
    • Know Labs, Inc. (NYSE:KNW) declined 19% to $0.6788.
    • Maxeon Solar Technologies, Ltd. (NASDAQ:MAXN) fell 19% to $4.9820. Goldman Sachs maintained Maxeon Solar Technologies with a Buy and lowered the price target from $18 to $11.
    • Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) fell 19% to $28.31 after announcing data from EMBARK Phase 2b study for biliary atresia.
    • Masonite International Corporation (NYSE:DOOR) fell 14.8% to $86.88 after the company announced the acquisition of PGT Innovations.
    • Ainos, Inc. (NASDAQ:AIMD) fell 13.5% to $2.87 after jumping 31% on Friday.
    • bluebird bio, Inc. (NASDAQ:BLUE) dipped 11% to $2.91.
    • LG Display Co., Ltd. (NYSE:LPL) fell 10.6% to $4.3510.
    • Lufax Holding Ltd (NYSE:LU) declined 10% to $3.1950. Lufax Holding announced that it received a letter from the NYSE dated notifying the company that it is below the NYSE's Continued Listing Standards.
    • Northann Corp. (NYSE:NCL) shares fell 9.3% to $14.44 after surging 42% on Friday.
    • Chavant Capital Acquisition Corp. (NASDAQ:CLAY) shares fell 9.2% to $9.53 after gaining 5% on Friday.
    • V.F. Corporation (NYSE:VFC) fell 7.7% to $18.38. VF Corp said on Dec. 13, it detected unauthorized occurrences on a portion of its IT systems.
    • Sunrun Inc. (NASDAQ:RUN) fell 6.2% to $17.48. Goldman Sachs maintained Sunrun with a Buy and raised the price target from $17 to $20.

     

    Now Read This: Ethereum Falls Below $2,200; Celestia, SATS Among Top Losers

    Get the next $ADD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADD
    $AHG
    $AIMD
    $ARQT

    CompanyDatePrice TargetRatingAnalyst
    Structure Therapeutics Inc.
    $GPCR
    3/26/2026Peer Perform
    Wolfe Research
    Cleveland-Cliffs Inc.
    $CLF
    3/25/2026Sector Weight
    KeyBanc Capital Markets
    Super Micro Computer Inc.
    $SMCI
    3/23/2026$22.00Outperform → Market Perform
    Northland Capital
    Gossamer Bio Inc.
    $GOSS
    3/23/2026Overweight → Neutral
    Cantor Fitzgerald
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Buy → Hold
    Argus
    Super Micro Computer Inc.
    $SMCI
    3/20/2026Market Perform → Market Underperform
    CJS Securities
    Lantheus Holdings Inc.
    $LNTH
    2/26/2026Mkt Perform → Outperform
    William Blair
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Neutral
    Wedbush
    More analyst ratings

    $ADD
    $AHG
    $AIMD
    $ARQT
    SEC Filings

    View All

    SEC Form 6-K filed by Lufax Holding Ltd

    6-K - Lufax Holding Ltd (0001816007) (Filer)

    3/27/26 4:11:40 PM ET
    $LU
    Finance: Consumer Services
    Finance

    SEC Form S-1 filed by Ideal Power Inc.

    S-1 - Ideal Power Inc. (0001507957) (Filer)

    3/27/26 4:07:33 PM ET
    $IPWR
    Semiconductors
    Technology

    Maison Solutions Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Maison Solutions Inc. (0001892292) (Filer)

    3/27/26 4:07:33 PM ET
    $MSS
    Food Chains
    Consumer Staples

    $ADD
    $AHG
    $AIMD
    $ARQT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lufax Announces the Resignation of Its General Manager

    SHANGHAI, March 27, 2026 /PRNewswire/ -- Lufax Holding Ltd (NYSE:LU), a leading financial services enabler for small business owners in China, today announced that Mr. Dongqi Chen has tendered his resignation as General Manager of the Company, effective March 31, 2026, due to his personal work arrangement.   The Company would like to take this opportunity to express its appreciation to Mr. Chen for his significant contribution to the Company during his tenure of office.About LufaxLufax is a leading financial services enabler for small business owners in China. Lufax offers financing products designed to address the needs of small business owners and others. In doing so, Lufax has established

    3/27/26 7:00:00 AM ET
    $LU
    Finance: Consumer Services
    Finance

    CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

    NAPLES, Fla. and CAMBRIDGE, United Kingdom, March 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced the filing of two new patent applications that further expand the Company's intellectual property portfolio surrounding tapinarof, a drug currently approved for the treatment of psoriasis and atopic dermatitis. The first newly filed patent covers a combination therapy pairing tapinarof with a class of drugs clinically proven in psoriasis and atopic dermatitis, while the second patent relates to novel cocrystal forms of tapinarof with these agents. CDT believes these developments may underpin a second-generation tapinarof product with enhance

    3/26/26 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

    Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi™ generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately 53,000 total prescriptions were filled for Emrosi™ during FY2025 Payer access for Emrosi™ available to over 100 million U.S. commercial lives Company to hold conference call today at 4:30 p.m. ET SCOTTSDALE, Ariz., March 25, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical," "the Company," "we" or "our"), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for t

    3/25/26 4:01:00 PM ET
    $DERM
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADD
    $AHG
    $AIMD
    $ARQT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ferber Alan bought $149,029 worth of shares (12,500 units at $11.92), increasing direct ownership by 19% to 77,134 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    3/4/26 4:06:55 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Somo David M bought $250,000 worth of shares (90,909 units at $2.75), increasing direct ownership by 37% to 338,347 units (SEC Form 4)

    4 - Ideal Power Inc. (0001507957) (Issuer)

    2/26/26 8:49:32 AM ET
    $IPWR
    Semiconductors
    Technology

    Director Camara Edilson bought $199,626 worth of shares (19,700 units at $10.13), increasing direct ownership by 88% to 41,983 units (SEC Form 4)

    4 - CLEVELAND-CLIFFS INC. (0000764065) (Issuer)

    2/13/26 11:23:21 AM ET
    $CLF
    Metal Mining
    Basic Materials

    $ADD
    $AHG
    $AIMD
    $ARQT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Structure Therapeutics

    Wolfe Research initiated coverage of Structure Therapeutics with a rating of Peer Perform

    3/26/26 8:59:27 AM ET
    $GPCR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    KeyBanc Capital Markets resumed coverage on Cleveland-Cliffs

    KeyBanc Capital Markets resumed coverage of Cleveland-Cliffs with a rating of Sector Weight

    3/25/26 8:29:13 AM ET
    $CLF
    Metal Mining
    Basic Materials

    Super Micro Computer downgraded by Northland Capital with a new price target

    Northland Capital downgraded Super Micro Computer from Outperform to Market Perform and set a new price target of $22.00

    3/23/26 8:27:58 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    $ADD
    $AHG
    $AIMD
    $ARQT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    February 21, 2025 - FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease

    For Immediate Release: February 21, 2025 Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol) for the treatment of cerebrotendinous xanthomatosis (CTX) in adults. Ctexli is the first FDA-approved drug to treat CTX, a very rare lipid storage disease.“The FDA is dedicated to supporting new drug development for rare diseases including very rare metabolic diseases like cerebrotendinous xanthomato

    2/21/25 11:48:20 AM ET
    $MIRM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    12/15/23 5:01:31 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADD
    $AHG
    $AIMD
    $ARQT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Liu Wenjuan

    3 - Akso Health Group (0001702318) (Issuer)

    3/27/26 6:46:26 AM ET
    $AHG
    Real Estate

    SEC Form 4 filed by Magnetar Financial Llc

    4 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Issuer)

    3/26/26 6:48:23 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Olson Dustin

    4 - PureCycle Technologies, Inc. (0001830033) (Issuer)

    3/24/26 8:40:06 AM ET
    $PCT
    Major Chemicals
    Industrials

    $ADD
    $AHG
    $AIMD
    $ARQT
    Leadership Updates

    Live Leadership Updates

    View All

    Super Micro Computer Announces Resignation of Board Member Yih-Shyan "Wally" Liaw

    DeAnna Luna Appointed Acting Chief Compliance OfficerSAN JOSE, Calif., March 20, 2026 /PRNewswire/ -- Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company") today announced that Yih-Shyan "Wally" Liaw ("Mr. Liaw") has resigned from the Company's Board of Directors, effective immediately. Following Mr. Liaw's resignation, the Company's Board comprises eight directors. There are no changes to the Board's committee structure. The Company also announced today that it has appointed DeAnna Luna as acting Chief Compliance Officer, effective immediately. Ms. Luna brings to this role more than two decades of experience in global trade compliance, governance, highly regulated markets

    3/20/26 4:38:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    The $17 Billion Solar Maintenance Market Just Got a New Player From the Defense Sector

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this article: VisionWave Holdings (NASDAQ:VWAV), First Solar (NASDAQ:FSLR), Enphase Energy (NASDAQ:ENPH), SunPower (NASDAQ:SPWR), SolarEdge Technologies (NASDAQ:SEDG) Key Takeaways: VisionWave Holdings (NASDAQ:VWAV) subsidiary SolarDrone has acquired a 51% controlling interest in Junko Solar, an Israeli solar panel maintenance and cleaning company, and appointed its founder Amos Cohen as SolarDrone CEO.The global solar panel operation and maintenance market is valued at $17 billion in 2026 and projected to reach nearly $60 billion by 2035, growing at a 13.3% CAGR[1].First Solar inaugurated a $1.1 billion AI-enabled manuf

    3/17/26 9:00:00 AM ET
    $ENPH
    $FSLR
    $SEDG
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    BRC Group Holdings, Inc. Announces Retirement of Approximately $37.9 Million in Outstanding Debt Through Bond-for-Equity Exchanges and Repurchases

    Redemption of Approximately $96 Million of  5.50% Senior Notes due 2026 (RILYK) on March 30, 2026Fourth Quarter and Full Year 2025 Financial Results to be Released by March 31, 2026 LOS ANGELES, March 12, 2026 /PRNewswire/ -- BRC Group Holdings, Inc. (NASDAQ:RILY) ("BRCGH" or the "Company"), today announced a series of transactions with a long-time institutional investor pursuant to Section 3(a)(9) of the Securities Act of 1933, which will, upon closing of the final transaction, result in the cancellation of 1,343,551 units of its publicly-traded senior notes across multiple outstanding series in exchange for the issuance of an aggregate of 4,201,300 shares of the Company's common stock at a

    3/12/26 4:45:00 PM ET
    $RILY
    Investment Managers
    Finance

    $ADD
    $AHG
    $AIMD
    $ARQT
    Financials

    Live finance-specific insights

    View All

    Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

    Total revenues were $61.9 million in FY2025 compared to $56.1 million in FY2024 Emrosi™ generated net revenues of $14.7 million during the full-year period after its launch in early April 2025 Approximately 53,000 total prescriptions were filled for Emrosi™ during FY2025 Payer access for Emrosi™ available to over 100 million U.S. commercial lives Company to hold conference call today at 4:30 p.m. ET SCOTTSDALE, Ariz., March 25, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical," "the Company," "we" or "our"), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for t

    3/25/26 4:01:00 PM ET
    $DERM
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Journey Medical Corporation to Announce Year End 2025 Financial Results on March 25, 2026

    SCOTTSDALE, Ariz., March 18, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical" or the "Company") (NASDAQ:DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration ("FDA")-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its year end 2025 financial results after the U.S. financial markets close on Wednesday, March 25, 2026. Journey Medical management will conduct a conference call and audio webcast on Wednesday, March 25, 2026 at 4:30 p.m. ET. To listen to the conference call, interested parties within the U.S. shoul

    3/18/26 8:30:00 AM ET
    $DERM
    $FBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

    - Following PROSERA Phase 3 topline results, the Company is focused on evaluating the totality of the dataset, engaging with the FDA, and assessing strategic options and capital allocation - - Enrollment in the Phase 3 SERANATA Study in PH-ILD has been paused while the Company evaluates implications of PROSERA results - - The Company implemented a reduction in force to align resources with near-term priorities - - Cash, cash equivalents and marketable securities totaled $137 million at year-end 2025 - Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH)

    3/17/26 4:01:00 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADD
    $AHG
    $AIMD
    $ARQT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Invivyd Inc.

    SC 13D/A - Invivyd, Inc. (0001832038) (Subject)

    12/12/24 4:39:09 PM ET
    $IVVD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $ADD
    $AHG
    $AIMD
    $ARQT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care